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Abstract
Background: Malfunctioning of the serotonergic system in Parkinson’s disease may contribute to non-motor symptoms
such as respiratory complications. Thus the aim of our study was to investigate the role of serotonin 5-HT2 receptors in
the modulation of normoxic breathing and the hypoxic ventilatory response (HVR) in rat model of Parkinson’s disease.
Methods: Wistar rats were lesioned unilaterally with double 6-hydroxydopamine (6-OHDA) injection to the right medial
forebrain bundle (MFB). Before lesion and two weeks later animals were put in whole body plethysmography chamber
and exposed to hypoxia (8% O2). Before hypoxic tests animals received intraperitoneal injections of DOI and ketanserin.
Efficacy of lesion was confirmed by cylinder test, assessing limb use asymmetry.
Results: Degeneration of the nigrostriatal pathway augmented response of tidal volume and minute ventilation
to hypoxia. DOI administration in control and lesion state caused a significant rise in normoxic respiratory rate
and minute ventilation. Yet, ventilatory response of these parameters to hypoxia was attenuated. Post-DOI magnitude
of HVR in lesioned state was decreased in compare to pre-lesion control. Subsequent ketanserin injection reverted
DOI-induced respiratory effects. We demonstrated that 6-OHDA treatment decreased the content of serotonin in the
injured striatum and on both sides of the brainstem, leaving the concentration of noradrenaline on unchanged level.
Conclusions: These observations showed that damage of the nigrostriatal system initiates changes in the serotonergic
system, confirmed by reduced concentration of serotonin in the striatum and brainstem, which affects the magnitude
of respiratory response to hypoxia after activation of 5-HT2 receptors.
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Background
Parkinson’s disease (PD), one of the most frequent
neurodegenerative diseases appearing in an old age, is
characterized by the progressive loss of dopamine
(DA) neurons in substantia nigra pars compacta (SN),
leading to striatal DA depletion [1, 2]. Apart from the
motor deficits patients with PD frequently exhibit
non-motor symptoms, which although significant are
still often undiagnosed and untreated [3]. Among the
latter are respiratory disturbances: restrictive pulmonary
function, respiratory dysrhythmias and upper airway
dysfunction [4, 5]. Ventilatory response to hypoxia (HVR)
has been examined in very few human studies, which
showed quite divergent results: enhanced response [6],
diminished [7, 8] and unchanged [9]. Latest animal
research on experimental PD models displayed mainly
increased response of tidal volume and attenuated
response of frequency of breathing to hypoxic stimulus,
ascribed mainly to dopamine brain depletion evoked by
6-hydroxydopamine [10] and reserpine administration
[11]. However, besides changes in dopaminergic neuro-
transmission serotonergic system undergoes degener-
ation in PD. Dystrophy and loss of serotonin producing
neurons has been observed in medullary raphe [12]
connected with brainstem regions of respiratory network
control like solitary tract nucleus (NTS) and Botzinger
and pre-Botzinger complex [13, 14].* Correspondence: kkaczynska@imdik.pan.pl1Laboratory of Respiration Physiology, Mossakowski Medical Research Centre
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Serotonin (5-HT) is a monoamine neurotransmitter,
engaged in stimulatory neuromodulation of the respira-
tory rhythm [15, 16]. Abnormal level of 5-HT metabo-
lites in the cerebrospinal fluid is considered to be linked
with attenuated ventilatory response to hypoxia observed
in Prader-Willi syndrome [14].
It has been confirmed that serotonin modulates dynamics
of hypoxic ventilatory response [17]. Moreover, stimulatory
5HT2 receptors in dorsomedial medulla oblongata have
been considered to be responsible for initiation of hypoxic
hyperventilation [18]. Chemical lesion of the raphe magnus,
where serotonergic neurons are present, produced in-
creased ventilatory response to hypoxia in awake rats
[19]. Similarly, extensive damage of medullary 5-HT
neurons in newborn piglets augmented respiratory
rate response to hypoxia during sleep [20].
We presume, that altered 5-HT neurotransmission in
PD [12] may be one of the reasons of respiratory dys-
functions present under normoxic and hypoxic condi-
tions. Therefore our first goal was the examination of
serotonin concentration in the striatum and brainstem
of the rats injected with 6-hydroxydopamine (6-OHDA)
into the medial forebrain bundle (MFB). Next, we investi-
gated the role of serotonin and serotoninergic 5HT2 recep-
tors in hypoxic ventilatory response in 6-OHDA treated
rats. This was achieved by intraperitoneal administration
before each hypoxic test DOI and ketanserin, 5HT2 recep-
tor agonist and antagonist, respectively.
Methods
Animals and experimental protocol
All experimental procedures were approved by the IV
Local Ethical Committee for Animal Experimentation
(Warsaw, Poland) and conducted in accordance with the
international/EU guidelines and regulations on the use
and care of laboratory animals. Young adult male Wistar
rats from MMRC PAS (Warsaw, Poland) weighing
230–260 g at the beginning of the experiment were
housed under standard laboratory conditions with a
12 h light/12 h dark cycle and unrestricted access to
food and water. Unilateral injection to the right MFB
with 6-hydroxydopamine (n = 9) or vehicle (n = 9) was
performed. All rats were investigated for hypoxic venti-
latory response before and fourteen days after injection.
Sham operation was aimed to show that surgical operation
itself and injection of the vehicle does not produce striatal
depletion of monoamines, motor deficits and changes in
normoxic and hypoxic breathing. Animals lesioned with 6-
OHDA after first control hypoxia were treated intraperito-
neally (i.p.) with DOI (2, 5-dimethoxy-4-iodoamphetamine)
at a dose of 1.5 mg kg−1 and after 30 min they were
exposed to second hypoxic test. Then animals received i.p.
administration of ketanserin at a dose of 1 mg kg−1 and
30 min later last hypoxic test was taken up. Each rat served
as its own control, thus the agonist and antagonist were
injected intraperitoneally twice in each rat; before and after
6-OHDA lesion. Period of 30 s breathing preceding hypoxia
was considered as a control normoxic breathing. Three
min period of hypoxic breathing was divided on 30 s time
periods and analyzed.
Experimental groups and paradigm:
I. sham operation and vehicle injection to the MFB;
hypoxic test before and two weeks after surgery
II. lesion with 6-OHDA to the MFB; control hypoxic
test + hypoxic test after DOI + hypoxic test after
ketanserin, prior to and two weeks after injury
(Fig. 1).
Surgery and 6-OHDA lesion
Rats were anesthetized with an intraperitoneal injection
of thiopentalum natricum (Sandoz GmbH, Austria) at a
dose of 90 mg kg−1. To prevent the uptake of 6-OHDA
by noradrenergic nerve terminals, 30 min before the
operation rats received i.p. administration of desipramine
hydrochloride (25 mg kg−1, Sigma Aldrich, Poland). After
positioning of the animal in a stereotaxic instrument (Digital
Lab Standard Stereotaxic Stoelting, USA) the skin was in-
cised, the skull was trephined with a dental drill in a specific
stereotaxic coordinates. Vehicle or 6-hydroxydopamine
hydrochloride (4 μg μl−1 dissolved in 0.9% NaCl containing
0.1% ascorbic acid (Sigma Aldrich, Poland)) was injected
with a sterile Hamilton micro syringe at a volume of 5 μl
(rate of 1 μl min−1) in two locations of the MFB. After injec-
tion, the needle was left in the brain for 5 min to prevent
the solution from flowing backward and then was slowly
retracted. Stereotaxic coordinates for the first injection site
were: antero-posterior, bregma: −2.2 mm, lateral: +1.5 mm,
ventral dura: −7.8 mm, and incisor bar: −3.5 mm,
and second site: antero-posterior, bregma: −4.4 mm,
lateral: +1.5 mm, ventral dura: −7.9 mm, and incisor
bar: −3.5 mm. After the surgery, rats were left to recover
with standard laboratory conditions, and unlimited access
to food and water.
Ventilatory recordings
Ventilatory measurements were performed in a whole
body rodent plethysmograph (WBP, model PLY 3223,
Buxco Electronics, USA). The system is composed of
two chambers: recording and reference. The pressure
fluctuations, created by the inspiration and expiration of
the animal in the experimental chamber, are propor-
tional to respiratory flow. Pressure changes within the
chamber are the result of gas compression caused by
pressure changes in the thoracic gas producing inspira-
tory and expiratory flow and of pressure changes within
the WBP chamber induced by changes in gas humidifi-
cation and temperature from air movement between the
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chamber and the lungs. The pressure difference between
the recording and reference chamber was measured with
a differential pressure transducer. The pressure signal
was amplified, filtered, recorded, and analyzed with data
analysis software (Biosystem XA for Windows, SFT3410
230 ver 2.9; Buxco Electronics, Wilmington, NC) generat-
ing tidal volume (VT, ml) and breathing frequency (f,
breaths min−1). Minute ventilation (VE, ml min
−1, BTPS)
was determined as a product of tidal volume and breathing
frequency. VT and VE were normalized to body weight
(ml kg−1 and ml kg−1 min−1, respectively). All experiments
were performed at room temperature (24–26 °C). Each rat
was placed in the chamber (4.7 L) and left for 30 min of
adjustment, while flushing with fraction of atmospheric air
at 2.5 L min−1 to prevent CO2 accumulation. After 30 min,
the gas mixture (atmospheric air) in the chamber was
switched to hypoxic mixture (8% of oxygen in 92% of
nitrogen). Gas equilibration time in the chamber took
50–60 s from a gas switch. After that time hypoxic test
consisting of 3 min of breathing with hypoxic mixture
was registered.
High-performance liquid chromatography (HPLC) analysis.
Assay of dopamine, serotonin, noradrenaline and
metabolites
Fourteen days following 6-hydroxydopamine or vehicle
injection to the MFB the animals were euthanized with
overdose of pentobarbital sodium and their brains were
instantly removed. The left and right striatum and
brainstem were dissected. The brainstem was then cut
on the left and right sides. Each tissue sample was weighed
and frozen (−80 °C) until further biochemical analysis.
Brain tissue was sonicated in ice-cold 0.1 M HClO4
solution and centrifuged (13000 rpm, 15 min at 4 °C) to
precipitate proteins. The supernatant was filtered (0.2 μm
pore size filter; Whatman, USA). The total tissue content of
dopamine and 3, 4-dihydroxyphenylacetic acid (DOPAC),
serotonin and its metabolite: 5-hydroxyindolacetic acid (5-
HIAA), noradrenaline (NA) and its metabolite: 3-methoxy-
4-hydroxyphenylglycol acid (MHPG), were analyzed using
high performance liquid chromatography with electro-
chemical detection (HPLC-ED) (L-3500 detector; Merck,
Germany) comprising a glassy carbon electrode. The elec-
trochemical potential was set at 0.8 V with respect to an
Ag/Ag Cl reference electrode. The aliquots (20 μl) were
separated on the column C – 18 (250 × 4.6 mm reverse
phase; Nucleosil, 5 μm, Macherey–Nagel, Germany). The
mobile phase consisted of 32 mM sodium phosphate
(Sigma-Aldrich, USA), 34 nM citric acid (Sigma-Aldrich,
USA), and 1 mM octane sulfonic acid (Sigma-Aldrich,
USA), and 54 μM ethylenediaminetetraacetic acid (EDTA;
Sigma-Aldrich, USA) was added to 18.3 mΩ purified
water containing 12% methanol (Merck, Germany). The
mobile phase flow rate was maintained at 0.8 ml min−1.
Samples were quantified by comparing with the stand-
ard (Sigma-Aldrich, USA) using ClarityChrom software
(Knauer, Germany) using an external standard calibration.
The contents of monoamines and parallel metabolites
were expressed as pg mg−1 fresh tissue.
Behavioral testing (cylinder test)
Each rat was tested twice, before lesion and two weeks
after. A forelimb use asymmetry test was performed to
evaluate the effectiveness of lesion evoked with 6-OHDA
injection, as previously described [10]. The cylinder test
was used to assess the degree of forepaw asymmetry.
The rat was placed in a transparent cylinder of 20 cm
diameter and 30 cm height. The number of each forepaw
contacts to the cylinder wall was recorded and counted for
a period of 5 min. The behavioral changes were quantified
based on the independent use of either the left or right
forelimb to contact the wall during landing and rearing.
Data and statistical analysis
The each individual value of tidal volume, minute venti-
lation and respiratory rate were determined by averaging
the variables measured for 10s of normoxic and post-
hypoxic respiration at chosen time points: 30s, 90s,
120 s, 150 s, 180 s and at 300 s (recovery after hypoxia).
To show magnitude of hypoxic response in both neuro-
logical states the data were expressed as % of post-hypoxic
change with reference to the control normoxic value
treated as a 100%. Numbers are reported as mean ± stand-
ard error of mean. The experimental data were analyzed
using two-way ANOVA (analysis of variance), followed by
repeated measurements with defined time points (prior to
and after hypoxia) and either injury status (before and
after lesion), or pre-treatment with serotonergic agents
Fig. 1 Scheme of the experimental protocol in 6-OHDA lesioned rats
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(prior to and after treatment), as a between condition
factor. Differences between individual time points and
experimental conditions were evaluated using the Newman-
Keuls post-hoc test. To assess differences in the contents of
5-HT, DA, NA and theirs metabolites between groups
(SHAM, 6-OHDA), a nonparametric Mann-Whitney
U-paired test was used. All values were considered as
statistically significant at P < 0.05. Statistical analysis was
performed using STATISTICA (StatSoft, Poland).
Results
Hypoxic ventilatory response in sham and 6-OHDA lesioned
rats
Figure 2 shows responses of respiratory variables to hypoxic
stimulus before and after sham (a, b, c) and 6-OHDA
(d, e, f ) lesion. The data were expressed as percentage
of post-hypoxic change with reference to the normoxic
values treated as a 100%. Administration of vehicle to
MFB had no influence on normoxic values of VT, f and
VE (data not shown). Magnitude of ventilatory response
to hypoxia displayed no significant differences prior to
and after sham lesion (Fig. 2a, b, c).
An unilateral injection of 6-OHDA to MFB reduced
normoxic values of frequency of breathing and minute
ventilation but did not alter control values of tidal volume
(data not shown). However, as we have displayed previously
[10] significant influence of nigrostriatal pathway degener-
ation on the increased respiratory response to hypoxia was
noticed (Fig. 2d, e, f). The augmentation of tidal volume
response to hypoxia was present at 30 s in comparison to
control pre-lesion state (Fig. 2d).
The initial growth of minute ventilation to hypoxic
stimulus present at 30s was significantly magnified in
6-OHDA treated state (above 25%). A significant
Fig. 2 Effects of vehicle (SHAM) or 6-OHDA injection to the MFB on hypoxic respiratory responses of VT (a, d), respiratory rate (b, e) and minute
ventilation (c, f). The data are expressed as percentage of change in reference to normoxic value considered as 100%. All values are means ±
SEM. *P < 0.05, **P < 0.01,***P < 0.001, versus the respective pre-hypoxic value; #P < 0.05, ##P < 0.01, versus the corresponding pre-lesion value;
(n = 5 (vehicle group), n = 9 (6-OHDA group))
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difference in VE between pre-lesion and post-lesion
state appeared at 30 s and from 120 s till 180 s (Fig. 2f ).
Involvement of 5HT2 receptors in normoxic and hypoxic
breathing in rats before and after implementation of the
PD model
Figure 3a, b, c depicts control normoxic respiratory
values after DOI and ketanserin injection in pre- and
post-lesion states. In normoxia DOI treatment produced
diminished tidal volume and increased frequency of
breathing and minute ventilation before and after 6-
OHDA injection (Fig 3a, b, c). Subsequent ketanserin
administration reverted respiratory variables to control
values.
DOI application had no effect on magnitude of VT
respiratory response to hypoxia before and after lesion
(Fig. 4a, b). Frequency of breathing during hypoxia was
significantly increased at 30 and 60s after DOI in PD
rats only (Fig. 4c, d). Post-DOI response of respiratory
rate to hypoxia was diminished by 29% in comparison to
control pre-DOI hypoxic response in both neurological
states, which was reverted by ketanserin administration
(Fig. 4c, d).
Minute ventilation was augmented during hypoxia
before and after DOI treatment in pre- and post-lesion
states. However, the response to hypoxia was reduced
in comparison to pre-DOI state. In the intact state VE
in response to hypoxia displayed reduced increase of
17% during the lifespan of stimulus in comparison to
control hypoxia. After 6-OHDA lesion to MFB DOI
evoked 32% decrease of minute ventilation response to
hypoxia (Fig. 4e, f ).
Concentration of dopamine, serotonin, noradrenaline and
metabolites in the striatum and brainstem
HPLC analysis confirmed substantial reduction of dopa-
mine and DOPAC concentration in the right lesioned stri-
atum in comparison to left striatum and both striata of
sham group. In the brainstem the content of dopamine
and its metabolite in ipsilateral and contralateral sides
was not disparate (Table 1). There were no dissimilarities in
noradrenaline contents in striatum and brainstem between
6-OHDA and vehicle injected animals (Table 1).
Unilateral injections of 6-OHDA into the right MFB
produced conspicuous reduction of 5-HT level (32%) in
right striatum in compare to tissue of sham operated
rats. This was accompanied by 30% increase in the con-
tent of serotonin metabolite: 5-HIAA and significant
increase of 5-HIAA/5-HT turnover at about 2.2 times
in collation to vehicle injected striatum (Fig. 5a, c).
Average concentration of 5-HT in the left intact stri-
atum of 6-OHDA treated group was also diminished by
32% in compare to left striatum of sham rats. Turnover
of 5-HIAA/5-HT was increased by 1.6 times, however
the level of 5-HIAA was not significantly distinct from
the left striatum of sham lesioned rats (Fig. 5a, c).
In the brainstem of 6-OHDA lesioned animals bilateral
reduction over 20% of serotonin was observed, compared
to sham group. This resulted in 1.3 higher 5-HIAA/5-HT
turnover in both sides of the brainstem of 6-OHDA
treated animals (Fig. 5b, c).
Cylinder test
Sham lesioned animals displayed no signs of asymmetry
and similar level of activity in comparison to pre-
injection state (data not shown). 6-OHDA lesioned rats
showed locomotor asymmetry, expressed by preference
usage of the right forepaw, ipsilateral to the site of
Fig. 3 Effects of i.p. injection of DOI and ketanserin on tidal volume
(a), frequency of breathing (b) and minute ventilation (c) in normoxic
condition in the intact rats and two weeks after lesion with 6-OHDA.
All values are means ± SEM. *P < 0.05 versus the respective control
value; ***P < 0.001, versus the respective control and post-ketanserin
values. #P < 0.05, ##P < 0.01, versus the corresponding value before and
after 6-OHDA treatment (n = 9)
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Fig. 4 Effects of i.p. injection of DOI and ketanserin on tidal volume response to hypoxia in the intact rats (a) and two weeks after lesion with
6-OHDA (b). Effects of i.p. injection of DOI and ketanserin on frequency of breathing response to hypoxia in the intact state (c) and two weeks
after lesion (d). Effects of i.p. injection of DOI and ketanserin on minute ventilation response to hypoxia in the intact rats (e) and two weeks after
lesion with 6-OHDA (f). The data are expressed as percentage of change in reference to normoxic value considered as 100%. All values are
means ± SEM. *P < 0.05, ***P < 0.001, versus the respective pre-hypoxic baseline value; #P < 0.05, ##P < 0.01, ###P < 0.001, versus the corresponding control
and post-ketanserin value; +P < 0.05, ++P < 0.01, versus the corresponding post-ketanserin value (n = 9)
Table 1 Concentration of dopamine (DA), 3,4-dihydroxyphenylacetic acid (DOPAC), noradrenaline (NA), and 3-methoxy-4-
hydroxyphenylglycol (MHPG) in respective left (L) and right (R) brain structures (striatum and brainstem) in sham and 6-OHDA treated
rats evaluated by HPLC detection ex vivo
Brain structure Dopamine Noradrenaline
DA DOPAC NA MHPG
Sham 6-OHDA Sham 6-OHDA Sham 6-OHDA Sham 6-OHDA
Striatum Left 9132 ± 599 7737 ± 1301 3665 ± 210 4956 ± 818 17.04 ± 1.4 18.00 ± 2.0 23.60 ± 3.9 11.71 ± 1.9
Right 8314 ± 861 63.7 ± 72.2* 3662 ± 264 5.37 ± 6.2* 26.63 ± 8.6 16.27 ± 7.0 32.52 ± 8.8 13.43 ± 1.4
Brainstem Left 40.20 ± 6.7 46.42 ± 5.2 29.51 ± 5.8 50.55 ± 3.9 623.81 ± 18.4 575.52 ± 15.4 1.76 ± 0.4 0.99 ± 0.2
Right 40.40 ± 4.5 29.81 ± 13.2 33.83 ± 3.4 27.89 ± 13.1 617.09 ± 20.1 573.21 ± 21.1 1.19 ± 0.3 1.02 ± 0.2
Data are expressed as mean ± SEM (in pg/mg). Significantly different values are in bold. *P < 0.05, comparison between sham and 6-OHDA groups
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neurotoxin injection (Fig. 6). Before lesion in the intact
state the animals touched the cylinder wall with right
or left forepaw proportionate number of times.
Discussion
We showed for the first time that alteration of serotonin
system provoked by unilateral injection of 6-OHDA into
the rat MFB affects hypoxic ventilatory response after
stimulation of 5-HT2 receptors. The most interesting
finding was correlation of serotonin level decline in stri-
atum and brainstem with decreased response of minute
ventilation to hypoxic stimulus after DOI injection.
6-hydroxydopamine injection to the MFB produced
over 90% depletion of dopamine in the striatum ipsilateral
to the site of the lesion, which we have shown also previ-
ously [10]. This time we displayed no alteration in nor-
adrenaline concentration and over 30% depletion of
serotonin in both striata and over 20% in both sides of the
brainstem.
Similar to our results, reduced level of serotonin and
increased turnover of 5-HIAA/5-HT in the brainstem
was described two weeks after intracerebroventricular
injection of 6-OHDA [21]. Higher change in striatal 5-HT
content (50%) and ratio of 5-HIAA/5-HT was found in the
MFB model, but after 6 weeks of neurotoxin application
[22]. Metabolism of serotonin is attained almost exclusively
via the monoamine oxidase and aldehyde dehydrogenase
action, resulting in the formation of terminal metabolite 5-
HIAA. Decline in 5-HT level in striatum and brainstem
and augmented ratio of 5-HIAA/5-HT particularly in
striatum, points to increased metabolism of serotonin. This
metabolic enhancement is officially considered as a com-
pensatory mechanism or neurochemical adaptation, the
result of which is to restore monoaminergic balance during
the initial phase of synaptic degeneration. Intensity and
duration of such adaptive reaction are strictly related to
metabolic reserve of injured neurons, even beyond the
dopaminergic tract [23].
This was revealed earlier that in Parkinson’s disease
and experimental models of PD apart from dopaminergic
pathways, also serotonergic system is liable to alterations
[24–26]. Degeneration of dopaminergic neurons caused
by 6-OHDA injection may have impact on brain level of
serotonin, electrophysiological characteristics of sero-
tonergic neurons and functioning of serotonergic re-
ceptors [12, 27].
Serotonin is important modulator of respiratory rhythm
and pattern, which was documented by research on trans-
genic mice lacking serotonergic neurons. The animals
displayed depressed ventilation and high frequency of
severe apnea [28]. Deficiency of serotonin in the nucleus
of solitary tract is reckoned to be related to pathogenesis
of sudden infant death syndrome (SIDS) [29]. The role of
serotonin in ventilatory response to hypoxia remains
Fig. 5 Concentration of serotonin (5-HT), 5-hydroxyindolacetic acid
(5-HIAA) (a, b) and 5-HIAA/5-HT turnover (c) in respective left (L) and
right (R) brain structures (striatum and brainstem) in sham and 6-
OHDA treated rats evaluated by HPLC detection ex vivo. All values
are means ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, comparison be-
tween sham and 6-OHDA treated groups (n = 8–9/per group)
Fig. 6 Effects of 6-OHDA injection on incidence of ipsilateral and
contralateral to lesion forepaw usage. 6-OHDA application caused
preference to use the right forelimb, ipsilateral to lesioned right MFB
during rearing and landing in the cylinder test. All values are
means ± SEM. *P< 0.05, versus the use of left or right forepaw in 6-OHDA
treated state; #P< 0.05, between pre- and post-lesion states
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undefined. Some studies pointed that caudal medullary
raphe and its serotoninergic neurons are not involved in
mediating respiratory response to hypoxia [30] and that
absence of serotonin in brains of genetically modified mice
has no impact on magnitude of ventilatory long term fa-
cilitation following intermittent hypoxia [31]. On the other
hand, serotonin released in the area of the dorsomedial
medulla oblongata containing NTS and nucleus of
hypoglossal nerve participated in initiation of hypoxic
ventilatory response and its depressive phase [18]. An-
tagonism of 5-HT2 receptors in this localization pro-
duced delayed post-hypoxic hyperventilation and
reduced depression phase [18].
Neuronal degeneration and dystrophic neurites in
serotonin-producing raphe nuclei has been evidenced
in Parkinson’s disease [32, 33]. Medullary raphe region
provides 5-HT innervation to the NTS [14], which
receives afferents from chemoreceptors of the carotid
body and sends direct efferent connections to respiratory
motor neurons influencing ventilatory response to hypoxia
[34]. Serotonergic boutons contacting cat NTS neurons
and phrenic motoneurons were immunohistochemically
demonstrated previously [35, 36].
We hypothesize that changes in serotonergic system
playing role in regulation of breathing contribute to
respiratory dysfunction present in PD such as dyspnea,
sleep apnea or altered ventilatory response to hypoxia
[4, 5, 7, 8]. Thus, the present study attempted to inves-
tigate the impact of nigrostriatal pathway degeneration
on breathing in normoxia and during hypoxic stimulus
after intraperitoneal administration of blood-brain barrier
permeating agonist and antagonist of 5-HT2 receptors;
DOI and ketanserin, respectively. DOI injection in both
neurological states: before and after lesion stimulated
respiratory rate and minute ventilation in normoxia. In
hypoxia decrease of response was observed for both
parameters in comparison to control pre-DOI hypoxic
response. Subsequent ketanserin administration inverted
normoxic respiration and respiratory response to hypoxia
to its control levels. Our results correspond with study by
Guner et al. [37], who showed that serotonin applied
intracerebroventricularly into chemodenervated rabbits
augmented VT and VE in normoxia, however diminished
ventilatory response to hypoxia. The authors speculated
that the latter could have been initiated by accumulation
of dopamine with its inhibitory influence on respiration. It
has been shown previously that DOI application aug-
mented release of dopamine, which was reverted by
blockade of 5-HT2 receptors [38, 39]. So conceivably,
in our study the agonist could modulate dopaminergic
system via stimulation of dopamine release and indir-
ectly decrease hypoxic ventilatory response. Infusion to
striatum compounds inhibiting reuptake of serotonin
combined with systemic injection of haloperidol
increased release of dopamine [40]. Studied in our re-
search model of PD is parallel to the state present
after haloperidol, which is considered as one of models
of Parkinson’s disease [41]. Thus, reduced response of
HVR in unilaterally lesioned rats could be the result of
increased dopamine release in the intact hemisphere.
Another plausible explanation of substantially dimin-
ished response of ventilation in response to hypoxia after
DOI (30%) in compare to HVR in pre-lesion state (17%)
could be the loss of balance between dopaminergic and
serotonergic system. When 30% depletion of serotonin
is accompanied by substantial of dopamine, activity of
serotonergic system may predominate. Therefore reduced
HVR after DOI in lesioned rats corresponds with inhibitory
action of endogenous and exogenous 5-HT on depressive
phase of ventilatory response to hypoxia [18, 30] and in-
verse stimulatory activity of 5-HT2 receptors’ antagonist on
hypoxic activity of phrenic nerve [42].
There are reports showing elevated level of 5-HT2A
receptor mRNA in the striatum and subthalamic nucleus in
the same unilateral MFB model of PD [43, 44]. It is possible
that similar upregulation of serotonin receptors could take
place also in our study. To our knowledge no studies
dealing with expression of brainstem 5-HT2 receptors
in PD have been performed. Nevertheless, we cannot
exclude that DOI is more potent in inhibiting hypoxic
response in our lesioned animals because of upregula-
tion of 5-HT2 receptors.
Tuppy et al. [45] evidenced that bilateral intrastriatal
6-OHDA injection evoked substantial reduction in neu-
rons in the ventral respiratory group (retrotrapezoid
nucleus, pre-Botzinger complex and rostral ventral re-
spiratory group), which correlated to the diminished
tachypneic response of frequency of breathing to hyper-
capnia. Although they studied PD model after three
times longer period of time we cannot rule out that loss
of respiratory neurons could appear in our study and
participate to reduced HVR after activation of 5-HT2
receptors.
Further studies are needed to define the role of sero-
tonergic system in altered hypoxic breathing in Parkinson’s
disease. Probably the use of bilateral model and examin-
ation of the expression of 5-HT2 receptors in the brainstem
would be more conclusive. An addressing the role of
another serotonin receptor in PD, like 5-HT3, which seems
to contribute to pathogenesis of SIDS, could be also very
important issue [30].
Conclusion
Here, we demonstrated that 6-OHDA induced damage
of the nigrostriatal pathway affects serotonergic sys-
tem, which was manifested by reduced levels of sero-
tonin in the striatum and brainstem and decreased
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respiratory response to hypoxia after activation of 5-
HT2 receptors. It implies that depletion of serotonin
in the brainstem may contribute to respiratory anom-
alies present in PD.
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